Afriplex is a South African company rooted in the development and manufacturing of botanical extracts, complementary medicines and food & beverage product solutions.

+27 (0)21 872 4976

+27 86 578 1305

Trading hours: Monday - Thursday (08:00-17:00) Fridays (08:00-16:30)


Afriplex News


Afriplex’s 2018 Technical Symposium in Gauteng

‘Harnessing Nature’s Best’ Afriplex is excited to announce that, back by popular demand, we will be hosting another one of our famous one-day technical symposiums. The theme for this year’s symposium is ‘Harnessing Nature’s Best’ and will explore the benefits of natural ingredients, taking us back to the efficacious preventative care that nature offers. The event will take place at the JSE Conference centre in Sandton, Johannesburg, on Wednesday 12 September 2018. Wayne Robinson, Director of Business Development, said: “We are thrilled that this year we can showcase our technical symposium to our Gauteng based clients. The international and local speakers have been...


NEW! – Afriplex Pelagon Range Set to Conquer Europe

While Afriplex has developed various extracts from the root of Pelargonium sidoides, a botanical well established in the bronchial health applications, the company has once again illustrated that they are ahead of the pack by designing an extract specifically for the food supplement sector. The Afriplex Pelagon range was developed with specialized applications in mind while being mindful of Europe’s current changing legislative environment. Pelargonium sidoides is a South African indigenous plant that has been used for centuries by the Zulu as a traditional remedy for the treatment of the upper respiratory tract ailments such as coughs, fever, bronchitis, pneumonia and...


Afriplex Releasing First SA-Developed Rooibos API (Active Pharmaceutical Ingredient)

Afriplex (Pty) Ltd, regarded one of the leaders in API development and production in South Africa, has partnered with the South African Medical Research Council (SAMRC) and Agricultural Research Council (ARC) to develop Afriplex GRT™. The end result is Afriplex GRT™, an active pharmaceutical ingredient (API) that will use naturally occurring flavonoid compounds found in rooibos to target specific metabolic syndrome-related dysfunctions in the body. Afriplex GRT™ is regarded as the first of its kind to be developed in South Africa. According to the World Health Organisation (WHO), the number of people with diabetes has risen from 108 million in 1980...


Afriplex Spreading Its Wings to The North

Afriplex is excited to announce that we have opened an office in Johannesburg, Gauteng. The new office will facilitate the company’s current marketing drive, creating awareness of our range of products and services that we provide to our existing and new clients in this region. Having a locally based office will ensure service excellence to customers in both Gauteng and Kwa-Zulu Natal. Afriplex has appointed Wayne Robinson as Director of Business Development in the Gauteng office. Wayne was the Sales, Operations and Technical Director as well as the Responsible Pharmacist for a pharmaceutical manufacturer for last nine years. He is the...


AFRIPLEX STRENGTHENS ITS POSITION IN THE MARKETPLACE AFTER SUCCESSFUL ACQUISITION! Afriplex is proud to announce that it recently acquired the Edelweiss Pharmaceutical business and is in the process of taking over the manufacturing of all solid dosage forms, namely tablets and capsules. In anticipation of increased business moving into their facility, Afriplex invested in their production plant and staff to ensure they have the infrastructure required to deliver a high level of service and good quality products to both their new and existing clients. Expansions will be completed by the end of February 2017. “Afriplex’s strategy is to maintain leadership in the complementary...


Afriplex Launches APIMF (Active Pharmaceutical Ingredient Master Files) Development Program

Afriplex is excited to announce a unique range of active pharmaceutical ingredients (API), supported by fully developed active pharmaceutical ingredient master files (APIMF). By utilising our research and development capabilities, we've expanded into APIMF development to support our range of API's such as Folicin A/T and Afriplex GRT. An APIMF describes the preparation, control and stability of the API and forms the basis of Module 3.2.S of the Common Technical Document (CTD). An API can be described as the drug substance or the active ingredient of a pharmaceutical product. Afriplex is excited to have launched this program and by working closely with...

The Impact of Amended Regulations on The Local CAMs (Complementary Medicines) Industry

Threat or opportunity? Afriplex recently positioned itself to be able to offer unique scientific, technical, legal and regulatory assistance by partnering with strategic role players in the cams industry. This network of experts include regulatory consultants, pharmacists and doctors who are equally passionate about overcoming the challenges associated with the recent legislative changes published into law on 15 november 2013. Recent amendments to the Medicines and Related Substances Act, 1965 (Act No. 101 of 1965) as outlined by the Department of Health (DoH) and Medicines Control Council (MCC) have set new boundaries for the marketing and sales of Complementary and Alternative Medicines...

Afriplex Returning to Its Roots as African Botanical Extracts Suppliers

[vc_row css=".vc_custom_1517459872281{padding-bottom: 10px !important;}"][vc_column][vc_column_text] After Aligning Itself With Role-Players In The International Food Supplement Arena, Afriplex Is Returning To Its Roots - Roots That Are Secured By Years Of Experience And Knowledge Of African Botanicals And Extraction Technology. The Company Would Like To Announce That It Will Again Be Supplying Its Well- Established African Botanicals And Extract Range To Its Customers. These Extracts Were Historically Developed For Applications In Various Industries, But With A Strong Focus On Client-Specific Tailoring. Over the past three years Afriplex has expanded its capacity and acquired additional technology, allowing for the production of not only standardized extracts,...